Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

Daughters with affected mothers may develop frontal fibrosing alopecia early.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Stem cell therapy shows promise in improving burn wound healing.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Stem cells from hair follicles in a special gel show strong potential for bone regeneration.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

Nanoparticles improve skin treatment but need more research on safety and effectiveness.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Engineered nanovesicles from hair follicle stem cells can effectively treat UVB-induced skin aging.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Thyroid disorders can cause skin issues in children, so early detection and screening are important.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

New medications could improve treatment for severe alopecia areata in Australia.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Hand and forearm transplants can be successful long-term, but they come with challenges like rejection and side effects from immunosuppression.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.